English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe International Parkinson Disease Genomics Consortium (IPDGC) reviews the progress made since it was founded ten years ago and looks ahead at future research priorities in the Journal of Parkinson’s Disease
Tag: Parkinson’s Disease
Study unravels new insights into a Parkinson’s disease protein
Research on alpha-synuclein highlights a potential therapeutic strategy
Study unravels new insights into a Parkinson’s disease protein
Research on alpha-synuclein highlights a potential therapeutic strategy
AI Therapeutics announces that a common LAM-002 mechanism in cancer and neurodegenerative diseases shows antitumor activity in the clinic and hope for ALS
Company receives FDA guidance for pivotal trial design in follicular lymphoma to support accelerated and full approval
Progress in unraveling the mystery of the genomics of Parkinson’s disease
The International Parkinson Disease Genomics Consortium (IPDGC) reviews the progress made since it was founded ten years ago and looks ahead at future research priorities in the Journal of Parkinson’s Disease
AI Therapeutics announces that a common LAM-002 mechanism in cancer and neurodegenerative diseases shows antitumor activity in the clinic and hope for ALS
Company receives FDA guidance for pivotal trial design in follicular lymphoma to support accelerated and full approval
Study unravels new insights into a Parkinson’s disease protein
Research on alpha-synuclein highlights a potential therapeutic strategy
AI Therapeutics announces that a common LAM-002 mechanism in cancer and neurodegenerative diseases shows antitumor activity in the clinic and hope for ALS
Company receives FDA guidance for pivotal trial design in follicular lymphoma to support accelerated and full approval
Progress in unraveling the mystery of the genomics of Parkinson’s disease
The International Parkinson Disease Genomics Consortium (IPDGC) reviews the progress made since it was founded ten years ago and looks ahead at future research priorities in the Journal of Parkinson’s Disease
World’s first ultra-high resolution 3D comprehensive mapping of human brain kicks off
New mapping technique using powerful x-ray technology will provide clear and detailed images of the brain and aid development of more effective treatments for neurodegenerative diseases
Journal of Parkinson’s Disease welcomes new Co-Editor-in-Chief Bastiaan R. Bloem
Amsterdam, NL, January 14, 2020 – The Journal of Parkinson’s Disease (JPD) is pleased to announce the appointment of Prof. Bastiaan (Bas) R. Bloem, MD, PhD, as the journal’s new Co-Editor-in-Chief. Bas joins Patrik Brundin, MD, PhD, who along with…
Fred H. Gage receives the ISSCR Achievement Award
Skokie, IL–The International Society for Stem Cell Research (ISSCR) will award its inaugural Achievement Award to Fred H. Gage, Ph.D., president of the Salk Institute for Biological Studies and the Vi and John Adler Chair for Research on Age-Related Neurodegenerative…
Susan Solomon earns the ISSCR Public Service Award
Skokie, IL–Susan L. Solomon, JD, chief executive officer and founder of The New York Stem Cell Foundation (NYSCF) Research Institute is the recipient of the 2020 International Society for Stem Cell Research (ISSCR) Public Service Award. The honor recognizes outstanding…
Gut bacteria could guard against Parkinson’s, study finds
A common bacteria that boosts digestive health can slow – and even reverse – build-up of a protein associated with Parkinson’s, new research suggests. Building on previous research linking brain function to gut bacteria, this study in a Parkinson’s model…
Journal of Parkinson’s Disease welcomes new Co-Editor-in-Chief Bastiaan R. Bloem
Amsterdam, NL, January 14, 2020 – The Journal of Parkinson’s Disease (JPD) is pleased to announce the appointment of Prof. Bastiaan (Bas) R. Bloem, MD, PhD, as the journal’s new Co-Editor-in-Chief. Bas joins Patrik Brundin, MD, PhD, who along with…
Fred H. Gage receives the ISSCR Achievement Award
Skokie, IL–The International Society for Stem Cell Research (ISSCR) will award its inaugural Achievement Award to Fred H. Gage, Ph.D., president of the Salk Institute for Biological Studies and the Vi and John Adler Chair for Research on Age-Related Neurodegenerative…
Susan Solomon earns the ISSCR Public Service Award
Skokie, IL–Susan L. Solomon, JD, chief executive officer and founder of The New York Stem Cell Foundation (NYSCF) Research Institute is the recipient of the 2020 International Society for Stem Cell Research (ISSCR) Public Service Award. The honor recognizes outstanding…
Gut bacteria could guard against Parkinson’s, study finds
A common bacteria that boosts digestive health can slow – and even reverse – build-up of a protein associated with Parkinson’s, new research suggests. Building on previous research linking brain function to gut bacteria, this study in a Parkinson’s model…
McGill researchers honored in Québec Science 2019 list of top discoveries
Four out of 10 top discoveries in 2019 led by McGill scientists
First patient for Parkinson’s disease trial recruited
The first patient has been recruited for a UK-wide trial into tackling one of the most disabling complications of Parkinson’s disease, led by the Royal United Hospitals Bath NHS Foundation Trust and the University of Bristol. The trial, funded by…
First patient for Parkinson’s disease trial recruited
The first patient has been recruited for a UK-wide trial into tackling one of the most disabling complications of Parkinson’s disease, led by the Royal United Hospitals Bath NHS Foundation Trust and the University of Bristol. The trial, funded by…
Neurons’ energy organelle protected from damage linked to ALS, Alzheimer’s
Potential medications to protect mitochondria found with novel screening strategy
Neurons’ energy organelle protected from damage linked to ALS, Alzheimer’s
Potential medications to protect mitochondria found with novel screening strategy
A better testing method for patients with Parkinson’s disease
Parkinson’s disease is a neurodegenerative disorder that manifests through symptoms such as tremor, slow movements, limb rigidity and gait and balance problems. As such, nearly all diagnostic testing revolves around how a patient moves and requires the patient to walk…
Bern and Fribourg researchers identify neurons responsible for rapid eye movements/REM during sleep
REM – Rapid Eye Movement – is not only the name of a successful American rock band, but also and not least a characteristic eye movement in paradoxical sleep, so in the stage with high dream activity. This sleep phase…
Bern and Fribourg researchers identify neurons responsible for rapid eye movements/REM during sleep
REM – Rapid Eye Movement – is not only the name of a successful American rock band, but also and not least a characteristic eye movement in paradoxical sleep, so in the stage with high dream activity. This sleep phase…
Scientists discover medicinal cannabis substitute for treating Parkinson’s disease
The drug, HU-308, lessens involuntary movements called dyskinesias, a side effect from years of treatment for Parkinson’s disease
Scientists discover medicinal cannabis substitute for treating Parkinson’s disease
The drug, HU-308, lessens involuntary movements called dyskinesias, a side effect from years of treatment for Parkinson’s disease
Parkinson’s symptoms improve with weekly regimens of both physical and cognitive exercises
Parkinson’s patients’ motor and non-motor symptoms were improved with a weekly exercise regimen that included physical and cognitive tasks, according to new research presented today (18 December) at The Physiological Society early career conference, Future Physiology 2019: Translating Cellular Mechanisms…
Parkinson’s symptoms improve with weekly regimens of both physical and cognitive exercises
Parkinson’s patients’ motor and non-motor symptoms were improved with a weekly exercise regimen that included physical and cognitive tasks, according to new research presented today (18 December) at The Physiological Society early career conference, Future Physiology 2019: Translating Cellular Mechanisms…
Nilotinib Appears Safe In Parkinson’s Trial; Drug Thought to Allow Dopamine Replenishment
A clinical trial investigating the repurposed cancer drug nilotinib in people with Parkinson’s disease finds that it is reasonably safe and well tolerated. Researchers also report finding an increase in dopamine, the chemical lost as a result of neuronal destruction, and a decrease in neurotoxic proteins in the brain among study participants. Finally, they say nilotinib, a tyrosine kinase inhibitor, potentially halts motor and non-motor decline.
Nilotinib appears safe in Parkinson’s trial; drug thought to allow dopamine replenishment
WASHINGTON – A clinical trial investigating the repurposed cancer drug nilotinib in people with Parkinson’s disease finds that it is reasonably safe and well tolerated. Researchers also report finding an increase in dopamine, the chemical lost as a result of…
Nilotinib appears safe in Parkinson’s trial; drug thought to allow dopamine replenishment
WASHINGTON – A clinical trial investigating the repurposed cancer drug nilotinib in people with Parkinson’s disease finds that it is reasonably safe and well tolerated. Researchers also report finding an increase in dopamine, the chemical lost as a result of…
New study enhances knowledge about widespread diseases
When proteins in the brain form deposits consisting of insoluble aggregates, diseases such as Alzheimer’s or Parkinson’s can occur. Now a research team has come a step closer to understanding this process. In Parkinson’s disease the alpha-synuclein (α-synuclein) protein forms…
New study enhances knowledge about widespread diseases
When proteins in the brain form deposits consisting of insoluble aggregates, diseases such as Alzheimer’s or Parkinson’s can occur. Now a research team has come a step closer to understanding this process. In Parkinson’s disease the alpha-synuclein (α-synuclein) protein forms…
High-tech method for uniquely targeted gene therapy developed
Neuroscientists at Lund University in Sweden have developed a new technology that engineers the shell of a virus to deliver gene therapy to the exact cell type in the body that needs to be treated. The researchers believe that the…
High-tech method for uniquely targeted gene therapy developed
Neuroscientists at Lund University in Sweden have developed a new technology that engineers the shell of a virus to deliver gene therapy to the exact cell type in the body that needs to be treated. The researchers believe that the…
Report discusses potential role of coffee in reducing risk of Alzheimer’s and Parkinson’s
Research suggests that a lifelong regular intake of coffee may have protective effect related to cognitive decline and neurodegenerative conditions1-3
Neurorestore: A Swiss initiative aimed at restoring lost neurological function
The Defitech Foundation has teamed up with EPFL, CHUV and UNIL to widen access to the groundbreaking neurotechnology developed under the 2018 STIMO study, which allowed paraplegic patients to walk again
Neurorestore: A Swiss initiative aimed at restoring lost neurological function
The Defitech Foundation has teamed up with EPFL, CHUV and UNIL to widen access to the groundbreaking neurotechnology developed under the 2018 STIMO study, which allowed paraplegic patients to walk again
New diagnostic techniques and drug may slow and even reverse cognitive decline from aging
BEER-SHEVA, ISRAEL and BERKELEY, CALIFORNIA…DECEMBER 4, 2019 – A groundbreaking clinical approach has been developed combining new diagnostic techniques to detect a leaking blood-brain barrier (BBB) with a new anti-inflammatory drug that for the first time slows or reverses age-related…
Brain diseases with molecular diversity
New insights into abnormal proteins in Parkinson’s disease and MSA
New diagnostic techniques and drug may slow and even reverse cognitive decline from aging
BEER-SHEVA, ISRAEL and BERKELEY, CALIFORNIA…DECEMBER 4, 2019 – A groundbreaking clinical approach has been developed combining new diagnostic techniques to detect a leaking blood-brain barrier (BBB) with a new anti-inflammatory drug that for the first time slows or reverses age-related…
Brain diseases with molecular diversity
New insights into abnormal proteins in Parkinson’s disease and MSA
Screening tech advances early detection of Parkinson’s disease
Pioneering technology can spot Parkinson’s when there are no obvious symptoms
Beware of swimming if you use deep brain stimulation for Parkinson’s
Case studies show good swimmers lose ability when device is on
Minimally invasive procedure relieves tremors in Parkinson’s patients
CHICAGO – A procedure that applies pulses of focused ultrasound to the brain is safe and effective for reducing tremors and improving quality of life in people with essential tremor (ET) or Parkinson’s disease (PD) tremor, according to a new…
Minimally invasive procedure relieves tremors in Parkinson’s patients
CHICAGO – A procedure that applies pulses of focused ultrasound to the brain is safe and effective for reducing tremors and improving quality of life in people with essential tremor (ET) or Parkinson’s disease (PD) tremor, according to a new…
Accelerating Medicines Partnership launches data knowledge portal for Parkinson’s disease
Shared platform to catalyze research collaboration toward biomarker discovery to advance the development disease therapies
Increased use of antibiotics may predispose to Parkinson’s disease
Higher exposure to commonly used oral antibiotics is linked to an increased risk of Parkinson’s disease according to a recently published study by researchers form the Helsinki University Hospital, Finland. The strongest associations were found for broad spectrum antibiotics and…